SOURCE: Endo Pharmaceuticals

April 20, 2007 11:27 ET

Endo Pharmaceuticals to Hold Conference Call on First Quarter 2007 Financial Results

CHADDS FORD, PA -- (MARKET WIRE) -- April 20, 2007 -- Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), a market leader in pain management, will announce its financial results for the first quarter ended March 31, 2007 before the market opens on April 27, 2007, and will hold a conference call at 11:00 a.m. ET that day to discuss these results.

Peter A. Lankau, President and Chief Executive Officer, and Charles A. Rowland, Jr., Executive Vice President and Chief Financial Officer, will host the call.

Investors and other interested parties may access the conference call as follows:

Telephone Numbers

866-713-8307 (domestic), (617) 597-5307 (international)

Passcode: 38589539

Please dial in 10 minutes prior to the scheduled start time.

Replay

A replay of the call will be available from April 27, 2007 at 1:00 p.m. ET by dialing (888) 286-8010 (domestic) or (617) 801-6888 (international), passcode 77753433, and will run until 12:00 a.m. ET on May 4, 2007.

Webcast

A simultaneous webcast of the call for interested investors and others may be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until 12:00 a.m. ET on May 4, 2007. The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.

About Endo

Endo Pharmaceuticals Holdings Inc. is a fully integrated specialty pharmaceutical company with market leadership in pain management products. Through its Endo Pharmaceuticals Inc. subsidiary, the company researches, develops, produces and markets a broad product offering of branded and generic pharmaceuticals, meeting the needs of healthcare professionals and consumers alike. More information, including this and past press releases of Endo Pharmaceuticals Holdings Inc., is available online at www.endo.com.